Cartesian Therapeutics
RNAC
#7455
Rank
$0.31 B
Marketcap
$12.34
Share price
-4.71%
Change (1 day)
-16.05%
Change (1 year)

Revenue for Cartesian Therapeutics (RNAC)

Revenue in 2024 (TTM): $38.91 Million USD

According to Cartesian Therapeutics's latest financial reports the company's current revenue (TTM ) is $38.91 Million USD. an increase over the revenue in the year 2023 that were of $26 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cartesian Therapeutics from 2015 to 2024

Annual revenue

Year Revenue Change
2024 $38.91 M49.64%
2023 $26 M-76.53%
2022 $0.11 B30.21%
2021 $85.07 M412.6%
2020 $16.59 M148.57%
2019 $6.67 M639.42%
2018 $0.9 M336.23%
2017 $0.2 M-97.44%
2016 $8.08 M34.47%
2015 $6.01 M